CADL

4.9852.83%
TJ

Theodore Jenkins

Vice President of Investor Relations & Business Development

Mr. Theodore Jenkins, also known as Ted, is Vice President of Investor Relations & Business Development of Candel Therapeutics, Inc. He served as Vice President of Corporate Strategy, Development and Investor Relations at Rock Creek Pharmaceuticals, Inc until October 2016. and served as its Secretary since August 14, 2015. Mr. Jenkins served as Vice President of Corporate Strategy and Development at Star Scientific, Inc. since February 2014. His experience encompasses an extensive 18-year Wall Street career as an institutional capital markets professional, working at top-tier, global and regional investment banks. He has a proven history of generating significant client revenue and communicating differentiated value with some of the largest investment managers in the United States. He has valuable insight, aptitude and knowledge from working with a wide spectrum of biotech and pharmaceutical healthcare disciplines derived from his close interaction with numerous companies in the sector and with specialist healthcare finance professionals. As a result, Mr. Jenkins has an abundance of relationships across the institutional and corporate banking investment community. His background includes nine years as a US Navy Officer serving as an aviator, flying F-14a tactical fighter aircraft and finishing his tour as a professional development instructor teaching midshipmen at the US Naval Academy in Annapolis, Maryland. Mr. Jenkins has a Master's of Science in Financial managemenr from The Johns Hopkins University from 1991 to 1994 and an BA degree in International Studies from Washington College in Chestertown, Maryland from 1981 to 1985.

Positions